These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33950495)

  • 1. Affinity Enrichment Chemoproteomics for Target Deconvolution and Selectivity Profiling.
    Werner T; Steidel M; Eberl HC; Bantscheff M
    Methods Mol Biol; 2021; 2228():237-252. PubMed ID: 33950495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of kinase inhibitor potencies in cell extracts by competition binding assays and isobaric mass tags.
    Hopf C; Eberhard D; Boesche M; Bastuck S; Dümpelfeld B; Bantscheff M
    Methods Mol Biol; 2012; 803():141-55. PubMed ID: 22065223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinase inhibitor profiling using chemoproteomics.
    Schirle M; Petrella EC; Brittain SM; Schwalb D; Harrington E; Cornella-Taracido I; Tallarico JA
    Methods Mol Biol; 2012; 795():161-77. PubMed ID: 21960222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells.
    Eberl HC; Werner T; Reinhard FB; Lehmann S; Thomson D; Chen P; Zhang C; Rau C; Muelbaier M; Drewes G; Drewry D; Bantscheff M
    Sci Rep; 2019 Oct; 9(1):14159. PubMed ID: 31578349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New affinity probe targeting VEGF receptors for kinase inhibitor selectivity profiling by chemical proteomics.
    Ku X; Heinzlmeir S; Helm D; Médard G; Kuster B
    J Proteome Res; 2014 May; 13(5):2445-52. PubMed ID: 24712744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized chemical proteomics assay for kinase inhibitor profiling.
    Médard G; Pachl F; Ruprecht B; Klaeger S; Heinzlmeir S; Helm D; Qiao H; Ku X; Wilhelm M; Kuehne T; Wu Z; Dittmann A; Hopf C; Kramer K; Kuster B
    J Proteome Res; 2015 Mar; 14(3):1574-86. PubMed ID: 25660469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors.
    Wong ML; Murphy J; Harrington E; Gower CM; Jain RK; Schirle M; Thomas JR
    Proteome Sci; 2016; 15():17. PubMed ID: 28725163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome-wide discovery of unknown ATP-binding proteins and kinase inhibitor target proteins using an ATP probe.
    Adachi J; Kishida M; Watanabe S; Hashimoto Y; Fukamizu K; Tomonaga T
    J Proteome Res; 2014 Dec; 13(12):5461-70. PubMed ID: 25230287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid profiling of protein kinase inhibitors by quantitative proteomics.
    Golkowski M; Brigham JL; Perera GK; Romano GE; Maly DJ; Ong SE
    Medchemcomm; 2014 Mar; 5(3):363-369. PubMed ID: 24648882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Photoaffinity Labeling-Based Chemoproteomics Strategy for Unbiased Target Deconvolution of Small Molecule Drug Candidates.
    Thomas JR; Brittain SM; Lipps J; Llamas L; Jain RK; Schirle M
    Methods Mol Biol; 2017; 1647():1-18. PubMed ID: 28808992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.
    Bantscheff M; Eberhard D; Abraham Y; Bastuck S; Boesche M; Hobson S; Mathieson T; Perrin J; Raida M; Rau C; Reader V; Sweetman G; Bauer A; Bouwmeester T; Hopf C; Kruse U; Neubauer G; Ramsden N; Rick J; Kuster B; Drewes G
    Nat Biotechnol; 2007 Sep; 25(9):1035-44. PubMed ID: 17721511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Proteomics-Based Drug Mechanism-of-Action Studies Using 16-Plex Isobaric Mass Tags.
    Zinn N; Werner T; Doce C; Mathieson T; Boecker C; Sweetman G; Fufezan C; Bantscheff M
    J Proteome Res; 2021 Mar; 20(3):1792-1801. PubMed ID: 33621079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Kinobeads Profiling for Target Identification of Irreversible Kinase Inhibitors.
    Dittus L; Werner T; Muelbaier M; Bantscheff M
    ACS Chem Biol; 2017 Oct; 12(10):2515-2521. PubMed ID: 28876896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Profiling of Protein Kinase Inhibitor Targets by Mass Spectrometry.
    Golkowski M; Maly DJ; Ong SE
    Methods Mol Biol; 2017; 1636():105-117. PubMed ID: 28730476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping protein complexes using covalently linked antibodies and isobaric mass tags.
    Dittmann A; Ghidelli-Disse S; Hopf C; Bantscheff M
    Methods Mol Biol; 2014; 1156():279-91. PubMed ID: 24791996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoproteomics-Aided Medicinal Chemistry for the Discovery of EPHA2 Inhibitors.
    Heinzlmeir S; Lohse J; Treiber T; Kudlinzki D; Linhard V; Gande SL; Sreeramulu S; Saxena K; Liu X; Wilhelm M; Schwalbe H; Kuster B; Médard G
    ChemMedChem; 2017 Jun; 12(12):999-1011. PubMed ID: 28544567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810.
    Colzani M; Noberini R; Romanenghi M; Colella G; Pasi M; Fancelli D; Varasi M; Minucci S; Bonaldi T
    Mol Cell Proteomics; 2014 Jun; 13(6):1495-509. PubMed ID: 24696502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Target Identification Using an iTRAQ-Based Quantitative Chemical Proteomics Approach-Based on a Target Profiling Study of Andrographolide.
    Wang J; Wong YK; Zhang J; Lee YM; Hua ZC; Shen HM; Lin Q
    Methods Enzymol; 2017; 586():291-309. PubMed ID: 28137568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling.
    Zhang L; Holmes IP; Hochgräfe F; Walker SR; Ali NA; Humphrey ES; Wu J; de Silva M; Kersten WJ; Connor T; Falk H; Allan L; Street IP; Bentley JD; Pilling PA; Monahan BJ; Peat TS; Daly RJ
    J Proteome Res; 2013 Jul; 12(7):3104-16. PubMed ID: 23692254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP.
    Duncan JS; Haystead TA; Litchfield DW
    Methods Mol Biol; 2012; 795():119-34. PubMed ID: 21960219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.